HLA class II transgenic mouse models for S. aureus infections and superantigens

用于金黄色葡萄球菌感染和超抗原的 HLA II 类转基因小鼠模型

基本信息

  • 批准号:
    8366719
  • 负责人:
  • 金额:
    $ 39.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-01 至 2017-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Staphylococcus aureus is a ubiquitous Gram-positive organism implicated in a spectrum of diseases; from benign, localized skin infections to life-threatening, systemic illnesses including pneumonia, sepsis and menstrual or non-menstrual toxic shock syndromes (TSS). The virulence and pathogenicity of S. aureus is attributed to its several exotoxins. The superantigen exotoxins (SAg) are important amongst them because SAg are the most potent activators of T lymphocytes known. Certain SAg could also be used as biological weapons. Thus, SAg are important from many perspectives. Nonetheless, the molecular pathways by which SAg participate in the disease pathogenesis have not been completely understood due to lack of good animal models. The conventional mouse strains are resistant to TSS due to poor binding of SAg to mouse MHC class II. However, SAg binds more efficiently to human MHC (called HLA) class I molecules. Therefore, mice transgenically expressing HLA class II molecules readily succumb to the pathogenic effects of SAg delivered through different routes and to S. aureus infection. As the disease caused by SAg in HLA class II (HLA-DR3) transgenic mice also closely mimics the syndrome in humans, they are ideal models. Using this mouse model we have demonstrated that interferon-gamma (IFN-?) dependent small intestinal pathology plays a critical role in lethality associated with TSS. However, the molecular pathways by which INF-¿ contributes to lethality in TSS, either directly or indirectly through other mediators, are not clear. Therefore, it is proposed to (1) Delineate th mechanisms by which IFN-¿ plays a lethal role in staphylococcal SAg-induced TSS. This will be achieved by generating bone marrow chimeras between HLA-DR3.IFN-?R+/+ and HLA-DR3.IFN-?R-/- mice. Bone marrow chimeras will be challenged with SEB and several molecular pathways will be compared. However, IFN-? is also important for immunity S. aureus infections. Therefore, it is proposed to (2) Determine the role of IFN-? in the pathogenesis and immunity to MRSA-induced pneumonia and sepsis. This wil be accomplished by inducing pneumonia and sepsis in HLA-DR3.IFN-?+/+ and HLA-DR3.IFN-?R-/- mice with the MRSA isolate, USA300. Several bacteriological, immunological, biochemical and pathological parameters including mortality will be compared between these two lines of mice. It is known that HLA class II polymorphisms could strongly influence the magnitude of T cell activation and IFN-? production in response to streptococcal SAg. However, the impact of HLA-DR and HLA-DQ polymorphisms on staphylococcal SAg-driven immuneresponses has not been investigated. Therefore, it is proposed to (3) Determine the extent to which staphylococcal superantigen-induced IFN-? production is modulated by HLA class II polymorphisms thereby influencing the outcome of MRSA-induced pneumonia and sepsis. This will be investigated by a series of in vivo studies using transgenic mice expressing HLA-DR2, HLA-DR3, HLA-DR4, HLA-DQ2, HLA-DQ6 or HLA-DQ8 molecules. PUBLIC HEALTH RELEVANCE: Staphylococcus aureus is a common, yet potentially dangerous bacterium. The occurrence of serious infections caused by the antibiotic resistant strains is increasing worldwide, which could be partly attributed to the ability of these strains t produce several harmful toxins. This study investigates the mechanisms of action of one such family of toxins called "superantigens". Also, the reasons as to why and how certain individuals might have different outcomes following an S. aureus infection will be studied using our humanized mice.
描述(申请人提供):金黄色葡萄球菌是一种普遍存在的革兰氏阳性微生物,涉及一系列疾病;从良性的局部皮肤感染到危及生命的全身疾病,包括肺炎、败血症和经期或非经期中毒性休克综合征(TSS)。金黄色葡萄球菌的毒力和致病性归因于其几种外毒素。超抗原外毒素(SAG)是其中重要的一种,因为SAG是已知的最有效的T淋巴细胞激活剂。某些SAG也可以用作生物武器。因此,从多个角度来看,SAG都很重要。然而,由于缺乏良好的动物模型,SAG参与该病发病的分子途径尚不完全清楚。由于SAG与小鼠MHC II类分子结合较差,常规小鼠株对TSS具有抗药性。然而,SAG能更有效地与人MHC I类分子结合。因此,转基因表达HLAII类分子的小鼠很容易屈服于SAG通过不同途径传递的致病作用和金黄色葡萄球菌感染。由于SAG在人类白细胞抗原II类(HL A-DR3)转基因小鼠体内引起的疾病也与人类相似,是理想的动物模型。利用这个小鼠模型,我们已经证明了干扰素-γ(IFN-?)依赖的小肠病理在与TSS相关的致命性中起着关键作用。然而,干扰素在TSS中直接或间接通过其他介体促进致死性的分子途径尚不清楚。因此,建议(1)阐明干扰素-β在葡萄球菌SAG诱导的TSS中起致死作用的机制。这将通过在人类白细胞抗原-DR3、干扰素-?R+/+和人类白细胞抗原-DR3.干扰素?R-/-小鼠之间产生骨髓嵌合体来实现。骨髓嵌合体将被SEB挑战,并将比较几种分子途径。然而,干扰素-?对金黄色葡萄球菌感染的免疫也很重要。因此,建议(2)确定干扰素的作用。在耐甲氧西林金黄色葡萄球菌肺炎和败血症的发病机制和免疫中的作用。这将通过用MRSA分离株USA300诱导人类白细胞抗原-DR3、干扰素?+/+和人类白细胞抗原-DR3、干扰素??R-/-小鼠的肺炎和败血症来实现。我们将在这两个品系的小鼠之间比较一些细菌学、免疫学、生化和病理学参数,包括死亡率。已知人类白细胞抗原II类基因多态性可强烈影响T细胞活化和干扰素的大小。对链球菌SAG的反应生产。然而,人类白细胞抗原-DR和人类白细胞抗原-DQ基因多态性对葡萄球菌SAG诱导的免疫应答的影响尚未被研究。因此,建议(3)确定葡萄球菌超抗原诱导的干扰素-?人类白细胞抗原II类基因的产生受到调节,从而影响耐甲氧西林金黄色葡萄球菌引起的肺炎和败血症的结局。这将通过一系列体内研究来进行,这些转基因小鼠表达了人类白细胞抗原DR2、人类白细胞抗原DR3、人类白细胞抗原DR4、人类白细胞抗原DQ2、人类白细胞抗原DQ6或人类白细胞抗原DQ8分子。 公共卫生相关性:金黄色葡萄球菌是一种常见但具有潜在危险的细菌。由抗生素耐药菌株引起的严重感染在全球范围内呈上升趋势,这可能部分归因于这些菌株产生多种有害毒素的能力。这项研究调查了一种被称为“超抗原”的毒素家族的作用机制。此外,某些人在感染金黄色葡萄球菌后可能会有不同结果的原因以及如何产生的原因将使用我们的人源化小鼠进行研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHELLA S DAVID其他文献

CHELLA S DAVID的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHELLA S DAVID', 18)}}的其他基金

A humanized transgenic mouse model for studying staphylococcal enterotoxin B
用于研究葡萄球菌肠毒素 B 的人源化转基因小鼠模型
  • 批准号:
    7497343
  • 财政年份:
    2007
  • 资助金额:
    $ 39.75万
  • 项目类别:
HLA class II transgenic mouse models for S. aureus infections and superantigens
用于金黄色葡萄球菌感染和超抗原的 HLA II 类转基因小鼠模型
  • 批准号:
    8646845
  • 财政年份:
    2007
  • 资助金额:
    $ 39.75万
  • 项目类别:
HLA class II transgenic mice as models for bacterial superantigen induced disease
HLA II 类转基因小鼠作为细菌超抗原诱导疾病的模型
  • 批准号:
    7382578
  • 财政年份:
    2007
  • 资助金额:
    $ 39.75万
  • 项目类别:
HLA class II transgenic mouse models for S. aureus infections and superantigens
用于金黄色葡萄球菌感染和超抗原的 HLA II 类转基因小鼠模型
  • 批准号:
    8468981
  • 财政年份:
    2007
  • 资助金额:
    $ 39.75万
  • 项目类别:
HLA class II transgenic mice as models for bacterial superantigen induced disease
HLA II 类转基因小鼠作为细菌超抗原诱导疾病的模型
  • 批准号:
    7596265
  • 财政年份:
    2007
  • 资助金额:
    $ 39.75万
  • 项目类别:
HLA class II transgenic mice as models for bacterial superantigen induced disease
HLA II 类转基因小鼠作为细菌超抗原诱导疾病的模型
  • 批准号:
    8033187
  • 财政年份:
    2007
  • 资助金额:
    $ 39.75万
  • 项目类别:
HLA class II transgenic mice as models for bacterial superantigen induced disease
HLA II 类转基因小鼠作为细菌超抗原诱导疾病的模型
  • 批准号:
    7792489
  • 财政年份:
    2007
  • 资助金额:
    $ 39.75万
  • 项目类别:
HLA class II transgenic mice as models for bacterial superantigen induced disease
HLA II 类转基因小鼠作为细菌超抗原诱导疾病的模型
  • 批准号:
    7212656
  • 财政年份:
    2007
  • 资助金额:
    $ 39.75万
  • 项目类别:
Role of HLA class II genes in demyelination
HLA II 类基因在脱髓鞘中的作用
  • 批准号:
    7099930
  • 财政年份:
    2006
  • 资助金额:
    $ 39.75万
  • 项目类别:
Role of HLA Class II Genes in Demyelination
HLA II 类基因在脱髓鞘中的作用
  • 批准号:
    8036554
  • 财政年份:
    2006
  • 资助金额:
    $ 39.75万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 39.75万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了